Joseph Lind - 15 Apr 2026 Form 4 Insider Report for Neuberger High Yield Strategies Fund Inc. (NHS)

Reporting relationship: Portfolio Manager
Issuer ticker: NHS
Reported as of: 15 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Apr 2026, 19:40:09 UTC
Prior SEC filing: 05 Jul 2023
Source filing: View source filing
Reporting owner signature: /s/ Jennifer R. Gonzalez, as attorney-in-fact for Joseph Lind

Filing notes and source

Key filing fact

Joseph Lind filed Form 4 for Neuberger High Yield Strategies Fund Inc. (NHS) on 24 Apr 2026.

Key facts

This page summarizes Joseph Lind's Form 4 filing for Neuberger High Yield Strategies Fund Inc. (NHS).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 24 Apr 2026, 19:40.

Change

Previous filing in this sequence was filed on 05 Jul 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001748786 Primary reporting owner

Lind Joseph

Relationship: Portfolio Manager
Address: C/O NEUBERGER BERMAN INVESTMENT ADVISERS, 1290 AVENUE OF THE AMERICAS, NEW YORK
Signature: /s/ Jennifer R. Gonzalez, as attorney-in-fact for Joseph Lind
Signature date: 24 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NHS transaction

Common Stock

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares: +12,833
Change %: +39%
Price: $6.50^*
Shares after: 45,333
Date: 15 Apr 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NHS transaction Derivative

Transferable Subscription Rights with Oversubscription Priv

Exercise of in-the-money or at-the-money derivative security

Transaction value
Shares: -12,833
Change %: -100%
Price
Shares after: 0
Date: 15 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,833
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Neuberger High Yield Strategies Fund Inc. (the "Fund") issued transferable subscription rights ("Rights") to its common stockholders of record as of the close of business on March 23, 2026 (the "Record Date") entitling the holders of these Rights to purchase additional shares of common stock of the Fund (the "Common Stock"). The holders of Common Stock of record on the Record Date ("Record Date Stockholders") were entitled to subscribe for additional shares of Common Stock at a discount to the market price of the Common Stock. The Fund distributed to Record Date Stockholders one Right for each share of Common Stock held on the Record Date. The Rights entitle their holders to purchase one new share of Common Stock for every three Rights held (1 for 3).

Footnote F2

Record Date Stockholders who fully exercised their Rights were entitled to subscribe, subject to certain limitations and subject to allotment, for additional shares of Common Stock which were not subscribed for (the "Over-Subscription Privilege"). The reporting person fully exercised all Rights received and subscribed for additional shares of Common Stock pursuant to the Over-Subscription Privilege, subject to the pro rata allocation of available shares of Common Stock. Fractional shares of Common Stock were not issued. The subscription period commenced on the Record Date and expired on April 15, 2026. On April 23, 2026, the third-party subscription agent for the Rights Offering determined the allocations to be made to the Record Date Stockholders who exercised their Over-Subscription Privilege. Shares reported include shares acquired through the Oversubscription Privilege.

Footnote F3

The final subscription price of $6.50 per share of Common Stock was determined based upon the terms of the offer. The Common Stock subscribed for will be issued after receipt of all stockholder payments.